UK's Oxford Biomedica tumbles on annual revenue forecast cut
07/08/2026 08:14
BUZZ-UK's Oxford Biomedica tumbles on annual revenue forecast cut
** Shares of cell and gene therapy manufacturer Oxford Biomedica OXB.L slump about 20% to 474p
** Cuts FY26 revenue forecast to £180 mln ($242.12 mln) to £200 mln from £220 mln to £240 mln earlier
** Says revised FY26 outlook reflects short-term shift in client ordering behaviour
** Reiterates FY27 revenue growth guidance of 25%-30%
** YTD, stock down about 4%, including session's move
($1 = 0.7434 pounds)
(Reporting by Krisha Bhatt in Bengaluru)